Vimarsana
Biggest News Aggregation in the World

Page 25 - Device Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Device Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Device Designation Today - Breaking & Trending Today

Sinaptica Looks to Treat Alzheimer's Disease Symptoms with Device - Vimarsana News

Sinaptica Looks to Treat Alzheimer's Disease Symptoms with Device

Sinaptica said it has won breakthrough device designation for its SinaptiStim technology.

Sinaptica Therapeutics obtains FDA Breakthrough Device Designation for Alzheimer's treatment - Vimarsana News

Sinaptica Therapeutics obtains FDA Breakthrough Device Designation for Alzheimer's treatment

The neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer's patients.

Viome Life Sciences raises $67M and more digital health fundings - Vimarsana News

Viome Life Sciences raises $67M and more digital health fundings

Genomic testing company Variantyx raised $20 million in debt financing, and mental health provider Mindful Care scooped up $7 million.

Viome Raises $67M to Expand Microbiome & At-Home Test Kits - Vimarsana News

Viome Raises $67M to Expand Microbiome & At-Home Test Kits

Viome Life Sciences, a mission-driven digital health company, announced additional $67M funding toward its Series C round.

CytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting - Vimarsana News

CytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

PRINCETON, N.J., Oct. 12, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions i...